APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEBy ApyxMedical|2025-12-12T19:31:44+00:00June 3, 2021|
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF RENUVION IN DERMAL RESURFACING PROCEDURESBy ApyxMedical|2025-12-12T19:32:06+00:00June 1, 2021|
